- Home
- SNT vs CLNN Comparison
SNT vs CLNN Comparison
Compare SNT & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- CLNN
- Stock Information
- Founded
- SNT 1965
- CLNN 2012
- Country
- SNT Canada
- CLNN United States
- Employees
- SNT N/A
- CLNN N/A
- Industry
- SNT Telecommunications Equipment
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- SNT Telecommunications
- CLNN Health Care
- Exchange
- SNT Nasdaq
- CLNN Nasdaq
- Market Cap
- SNT 36.6M
- CLNN 43.0M
- IPO Year
- SNT 1993
- CLNN N/A
- Fundamental
- Price
- SNT $2.64
- CLNN $4.53
- Analyst Decision
- SNT
- CLNN Strong Buy
- Analyst Count
- SNT 0
- CLNN 4
- Target Price
- SNT N/A
- CLNN $59.25
- AVG Volume (30 Days)
- SNT 83.8K
- CLNN 54.9K
- Earning Date
- SNT 11-12-2024
- CLNN 11-13-2024
- Dividend Yield
- SNT N/A
- CLNN N/A
- EPS Growth
- SNT N/A
- CLNN N/A
- EPS
- SNT 0.05
- CLNN N/A
- Revenue
- SNT $34,455,000.00
- CLNN $421,000.00
- Revenue This Year
- SNT N/A
- CLNN N/A
- Revenue Next Year
- SNT N/A
- CLNN $1,058.37
- P/E Ratio
- SNT $52.60
- CLNN N/A
- Revenue Growth
- SNT 2.04
- CLNN N/A
- 52 Week Low
- SNT $1.08
- CLNN $3.82
- 52 Week High
- SNT $2.64
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- SNT 92.07
- CLNN 34.27
- Support Level
- SNT $2.24
- CLNN $5.00
- Resistance Level
- SNT $2.50
- CLNN $6.04
- Average True Range (ATR)
- SNT 0.15
- CLNN 0.52
- MACD
- SNT 0.12
- CLNN -0.17
- Stochastic Oscillator
- SNT 100.00
- CLNN 8.80
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).